Changes in Glutamatergic Neurotransmission of Severe TBI Patients

Stopped Given CoVid-19 pandemic we could not recruit subjects/patients for the 1st year. Currently waiting for new sponsor to fulfill the aims.

Conditions

• Disorder of Consciousness
• Traumatic Brain Injury

Interventions

• DRUG: Amantadine + L-DOPA
• DRUG: NMDA blocker

Sponsor

Weill Medical College of Cornell University